1. Home
  2. CHMI vs PYXS Comparison

CHMI vs PYXS Comparison

Compare CHMI & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • PYXS
  • Stock Information
  • Founded
  • CHMI 2012
  • PYXS 2018
  • Country
  • CHMI United States
  • PYXS United States
  • Employees
  • CHMI N/A
  • PYXS N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • PYXS Health Care
  • Exchange
  • CHMI Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • CHMI 89.2M
  • PYXS 75.0M
  • IPO Year
  • CHMI 2013
  • PYXS 2021
  • Fundamental
  • Price
  • CHMI $2.79
  • PYXS $1.14
  • Analyst Decision
  • CHMI Hold
  • PYXS Strong Buy
  • Analyst Count
  • CHMI 2
  • PYXS 5
  • Target Price
  • CHMI N/A
  • PYXS $9.00
  • AVG Volume (30 Days)
  • CHMI 338.7K
  • PYXS 706.6K
  • Earning Date
  • CHMI 08-07-2025
  • PYXS 08-13-2025
  • Dividend Yield
  • CHMI 21.50%
  • PYXS N/A
  • EPS Growth
  • CHMI N/A
  • PYXS N/A
  • EPS
  • CHMI N/A
  • PYXS N/A
  • Revenue
  • CHMI $27,506,000.00
  • PYXS N/A
  • Revenue This Year
  • CHMI N/A
  • PYXS N/A
  • Revenue Next Year
  • CHMI $54.92
  • PYXS N/A
  • P/E Ratio
  • CHMI N/A
  • PYXS N/A
  • Revenue Growth
  • CHMI 19.59
  • PYXS N/A
  • 52 Week Low
  • CHMI $2.34
  • PYXS $0.83
  • 52 Week High
  • CHMI $3.95
  • PYXS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 45.14
  • PYXS 51.02
  • Support Level
  • CHMI $2.73
  • PYXS $1.04
  • Resistance Level
  • CHMI $2.82
  • PYXS $1.24
  • Average True Range (ATR)
  • CHMI 0.08
  • PYXS 0.08
  • MACD
  • CHMI -0.01
  • PYXS -0.00
  • Stochastic Oscillator
  • CHMI 40.00
  • PYXS 53.57

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: